Person Prof Ian Alexander National Health and Medical Research Council Viewed: [[ro.stat.viewed]] Click to explore relationships graph Help Related Grants and Projects Participant in Directed evolution of AAV capsid variants for enhanced targeted genome editing in the human liver (funded by National Health and Medical Research Council) Principal investigator of Hepatocellular Carcinoma: understanding the genotoxic risks of liver-targeted gene therapy using recombinant AAV vectors (funded by National Health and Medical Research Council) Participant in Preclinical Assessment of Gene Therapy for Ventricular Arrhythmia (funded by National Health and Medical Research Council) Participant in Reversal of diabetes in a humanised mouse using a clinically applicable vector system (funded by National Health and Medical Research Council) Principal investigator of Treatment of genetic liver disease by homologous recombination in vivo, coupled with a pharmoco-genetic strategy for selective expansion of genetically repaired hepatocytes (funded by National Health and Medical Research Council) User Contributed Tags Login to tag this record with meaningful keywords to make it easier to discover Saved to MyRDA Save to MyRDA
Click to explore relationships graph Help Related Grants and Projects Participant in Directed evolution of AAV capsid variants for enhanced targeted genome editing in the human liver (funded by National Health and Medical Research Council) Principal investigator of Hepatocellular Carcinoma: understanding the genotoxic risks of liver-targeted gene therapy using recombinant AAV vectors (funded by National Health and Medical Research Council) Participant in Preclinical Assessment of Gene Therapy for Ventricular Arrhythmia (funded by National Health and Medical Research Council) Participant in Reversal of diabetes in a humanised mouse using a clinically applicable vector system (funded by National Health and Medical Research Council) Principal investigator of Treatment of genetic liver disease by homologous recombination in vivo, coupled with a pharmoco-genetic strategy for selective expansion of genetically repaired hepatocytes (funded by National Health and Medical Research Council) User Contributed Tags Login to tag this record with meaningful keywords to make it easier to discover
